BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Pharm Country

  NPS Pharmaceuticals, Inc. Plans $41.29 Million Public Offering Of Common Shares

  September 16, 2010

   · 

  3 min read
• Business

  FluoroPharma Appoints Mr. Thijs Spoor as Chief Executive Officer and Director

  September 16, 2010

   · 

  3 min read
• BioCapital

  Genzyme Corporation Sees End to Fabrazyme Rationing

  September 16, 2010

   · 

  1 min read
• Deals

  Immune Network Ltd. Announces Intent to Acquire Oral Vaccine Technology Platform from Immunitor

  September 16, 2010

   · 

  2 min read
• Pharm Country

  NMS Labs Now Performs Urine Tests for Metabolites of Synthetic Cannabinoids Found in K2 and Spice

  September 16, 2010

   · 

  1 min read
• Biotech Beach

  Shrink Nanotechnologies Provides Update on Projects and Commercialization Efforts

  September 16, 2010

   · 

  1 min read
• Business

  Baxter International, Inc. Third Quarter 2010 Financial Results Conference Call

  September 16, 2010

   · 

  1 min read
• BioForest

  Biotechnology Industry Organization (BIO) Announces Plenary Sessions and Business Roundtables Featured at 9th Annual BIO Investor Forum

  September 16, 2010

   · 

  1 min read
• Drug Development

  Biocryst Pharmaceuticals Gout Drug Shows Promise in Mid-Stage Trial

  September 16, 2010

   · 

  5 min read
• Drug Development

  Phase I/II Data Published in New England Journal of Medicine Demonstrate that Incyte Corporation JAK Inhibitor, INCB18424, Provides Marked and Durable Clinical Benefits in Patients with Myelofibrosis, a Rare, Life-Threatening Blood Cancer

  September 16, 2010

   · 

  1 min read